-
Silvia Rivara,
Giovanni Piersanti,
Francesca Bartoccini, Giuseppe Diamantini,
Daniele Pala,
Teresa Riccioni,
Maria Antonietta Stasi,
Walter Cabri,
Franco Borsini,
Marco Mor,
Giorgio Tarzia,
Patrizia Minetti
[show abstract]
[hide abstract]
ABSTRACT: A systematic modification of the caffeinyl core and substituents of the reference compound (E)-8-(3-chlorostyryl)caffeine led to the 9-deazaxanthine derivative (E)-6-(4-chlorostyryl)-1,3,5,-trimethyl-1H-pyrrolo[3,2-d]pyrimidine-2,4-(3H,5H)-dione (17f) which acts as a dual antagonist of human A2a/MAO-B inhibitor (Ki(A2A) = 260 nM; IC50(MAO-B) = 200 nM; IC50(MAO-A) = 10 μM) and dose dependently counteracts haloperidol-induced catalepsy in mice from 30 mg/kg by the oral route. The compound is the best balanced A2A antagonist /MAO-B inhibitor reported to date and it could be considered as a new lead in the field of anti-Parkinson's agents. A number of analogs of 17f were synthesized and qualitative SARs are discussed. Two analogs of 17f, namely 18b and 19a, inhibit MAO-B with IC50 of 68 nM and 48 nM, respectively, being from five to seven folds more potent than the prototypical MAO-B inhibitor deprenyl (IC50 = 334 nM).
Journal of Medicinal Chemistry 01/2013; · 4.80 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Candida albicans is the most prevalent fungal pathogen in humans. In this study, flavonoids from unprocessed multifloral honey were extracted and investigated their anticandidal activity in vitro. These results indicated that honey flavonoids inhibited Candida growth; however, they did not kill the yeasts and did not directly affect the cytoplasmic membrane. The viability tests of cells yeast with the fluorescent probe Sybr green I in combination with propidium iodide suggested that antifungal activity of honey flavonoids depended on their relative lipophilic properties and that they may reach a possible intracellular site of action without compromising membrane-associated functions.
International Journal of Food Properties 07/2011; 14(4):799-808. · 0.67 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A practical and efficient synthesis of 3-substituted hexahydropyrrolo[2,3-b]indole is described. The addition/cyclization of 3-substituted indoles with alpha,beta-dehydroamino esters in the presence of a Lewis acid provides hexahydropyrrolo[2,3-b]indole adducts in good yields and stereoselectivities. This approach has been applied to the concise synthesis of esermethole employing an appropriately substituted indole and an N-acyl dehydroamino ester.
Organic Letters 09/2010; 12(17):3844-7. · 5.86 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: 5,6,11,12,17,18,23,24-Octahydrocyclododeca[1,2-b:4,5-b':7,8-b'':10,11- b''']tetrai ndole (CTet), an indole-3-carbinol (I3C) metabolite endowed with anticancer properties, is poorly soluble in the solvents most frequently used in biological tests. This study indicates that the use of gamma-cyclodextrin (gamma-CD) avoids this problem. Formulated with gamma-CD CTet is a potent inhibitor of DNA synthesis in both estrogen receptor positive (MCF-7) and estrogen receptor negative (MDA-MB-231) human breast cell lines (IC50 = 1.20 +/- 0.04 microM and 1.0 +/- 0.1 microM, respectively).
Molecules 06/2010; 15(6):4085-93. · 2.39 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Octahydrocyclododeca[1,2-b:4,5-b':7,8-b'':10,11-b''']tetraindole (CTet) Abstract: 5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b':7,8-b'':10,11-b''']tetrai ndole (CTet), an indole-3-carbinol (I3C) metabolite endowed with anticancer properties, is poorly soluble in the solvents most frequently used in biological tests. This study indicates that the use of γ-cyclodextrin (γ-CD) avoids this problem. Formulated with γ-CD CTet is a potent inhibitor of DNA synthesis in both estrogen receptor positive (MCF-7) and estrogen receptor negative (MDA-MB-231) human breast cell lines (IC 50 = 1.20 ± 0.04 μM and 1.0 ± 0.1 μM, respectively).
Molecules. 01/2010; 15:4085-4093.
-
Gilberto Spadoni,
Annalida Bedini, Giuseppe Diamantini,
Giorgio Tarzia,
Silvia Rivara,
Simone Lorenzi,
Alessio Lodola,
Marco Mor,
Valeria Lucini,
Marilou Pannacci,
Alessia Caronno,
Franco Fraschini
[show abstract]
[hide abstract]
ABSTRACT: Racemic N-(8-methoxy-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-10-ylmethyl)acetamide (compound 5) was previously identified as a novel selective MT(2) antagonist fulfilling the requirements of pharmacophore and 3D QSAR models. In this study the enantiomers of 5 were separated by medium-pressure liquid chromatography and behaved as the racemate. Compound 5 was modified at the acylaminomethyl side chain and at position C8. The resulting analogues generally behaved as melatonin receptor antagonists (GTPgammaS test) with a modest degree of selectivity (up to 10-fold) for the MT(2) receptor. Changes at the amide side chain led to a decrease in binding affinity, whereas 8-acetyl and 8-methyl derivatives 12 and 11, respectively, were as potent as the 8-methoxy parent compound 5. Docking experiments with an MT(2) receptor model suggested binding modes consistent with the observed SARs and with the lack of selectivity of the enantiomers of 5.
ChemMedChem 01/2008; 2(12):1741-9. · 3.15 Impact Factor
-
Flavia Radogna,
Laura Paternoster,
Maria Cristina Albertini,
Claudia Cerella,
Augusto Accorsi,
Anahi Bucchini,
Gilberto Spadoni, Giuseppe Diamantini,
Giorgio Tarzia,
Milena De Nicola,
Maria D'Alessio,
Lina Ghibelli
[show abstract]
[hide abstract]
ABSTRACT: Among the non-neurological functions of melatonin, much attention is being directed to the ability of melatonin to modulate the immune system, whose cells possess melatonin-specific receptors and biosynthetic enzymes. Melatonin controls cell behaviour by eliciting specific signal transduction actions after its interaction with plasma membrane receptors (MT(1), MT(2)); additionally, melatonin potently neutralizes free radicals. Melatonin regulates immune cell loss by antagonizing apoptosis. A major unsolved question is whether this is due to receptor involvement, or to radical scavenging considering that apoptosis is often dependent on oxidative alterations. Here, we provide evidence that on U937 monocytic cells, apoptosis is antagonized by melatonin by receptor interaction rather than by radical scavenging. First, melatonin and a set of synthetic analogues prevented apoptosis in a manner that is proportional to their affinity for plasma membrane receptors but not to their antioxidant ability. Secondly, melatonin's antiapoptotic effect required key signal transduction events including G protein, phospholipase C and Ca(2+) influx and, more important, it is sensitive to the specific melatonin receptor antagonist luzindole.
Journal of Pineal Research 10/2007; 43(2):154-62. · 5.79 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: In this study we investigated some biological properties of flavonoids recovered in the aqueous (AqE) and ether (EtE) extracts from four Italian multifloral honeys. In particular, a cell-free assay was employed to detect direct reduction of ferricyanide, whereas an assay using intact human erythrocytes was used to measure the ability to donate electrons to a trans-plasma membrane oxidoreductase. It was found that the AqE displays greater "in vitro" ferricyanide-reducing activity than the EtE but, unlike the latter, is virtually ineffective in the cell-based assay. Uptake studies employing high-performance liquid chromatography/mass spectrometry (HPLC/MS) showed that the different results were explained by the inability of AqE components to cross the erythrocyte plasma membrane and by the excellent uptake of EtE flavonoids, which, once within the cell, donate electrons to the membrane oxidoreductase to efficiently reduce extracellular oxidants. The latter property appears to depend on the content of ether-soluble flavonoids in the starting honeys.
Journal of Agricultural and Food Chemistry 11/2006; 54(21):8328-34. · 2.82 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: 3-(Acetylaminomethyl)-2-(ethoxycarbonyl)-6-methoxy-1,3,4,5-tetrahydrobenzo[cd]indole (2) is a rigid melatonin analogue that as a racemate displays about the same affinity and intrinsic activity of melatonin (1) in in vitro experiments. We report here the resolution of the racemate by preparative medium pressure liquid chromatography (MPLC) and the X-ray determination of the R absolute configuration of the (-)-enantiomer. The two enantiomers were separately tested as MT1 and MT2 ligands, and the (+)-(S)-2 showed a potency comparable to that of melatonin and about three orders of magnitude greater than that of its enantiomer. The information obtained by crystallographic analysis and NMR studies about the conformational preference for 2 and by the pharmacological characterization of (R)-2 and (S)-2 was employed in a molecular modeling study, aimed at reassessing the melatonin receptor pharmacophore model for agonist compounds. Chiral enantioselective agonists reported in the literature were also included in the study.
Bioorganic & Medicinal Chemistry 06/2006; 14(10):3383-91. · 2.92 Impact Factor
-
Gilberto Spadoni, Giuseppe Diamantini,
Annalida Bedini,
Giorgio Tarzia,
Federica Vacondio,
Claudia Silva,
Mirko Rivara,
Marco Mor,
Pier Vincenzo Plazzi,
Morena Zusso,
Davide Franceschini,
Pietro Giusti
[show abstract]
[hide abstract]
ABSTRACT: 5-Methoxy-2-(N-acetylaminoethyl)indole (5d), a melatonin analogue derived from the transposition of the acetylaminoethyl side chain from C3 to C2 of the indole nucleus, had been previously characterized as a low affinity antagonist at MT1 and MT2 membrane receptors; this molecule is endowed with good in vitro antioxidant and cytoprotective potency in rat cerebellar cell cultures, comparable to or better than those of melatonin. In order to further investigate the role of structure-antioxidant activity relationships in cytoprotection, the structure of 5d was systematically modulated to design a new series of compounds. The 5-methoxy group was replaced by substituents with different electronic and lipophilic properties and it was moved to a different position on the indole ring. Other modifications of the lead structure involved the methylation of the indole nitrogen or its replacement by a sulfur atom. The side chain was also modified either increasing its lipophilicity or introducing an ionisable acid group. The antioxidant activity of this set of compounds was evaluated by the ABTS and conjugated dienes (CD) assays, while their cytoprotection was evaluated against kainate-induced cytotoxicity in cultured cerebellar neurons. In both antioxidant assays, the shift of the 5-methoxy group to the 4-position of the indole nucleus led to the most active radical scavenger (9), more potent than the parent compound and melatonin in the antioxidant tests, but much less effective as a cytoprotectant. Sharp structure-activity relationships were registered for cytoprotection, where the maintenance of the 5-alkoxy-2-(N-acylaminoethyl)indole scaffold appeared as the key feature to confer both antioxidant and cytoprotective activity to the structure. Some derivatives of the set, however, together with the most potent 5d, maintained a significant antioxidant and cytoprotective effect and could be employed as tools for in vivo pharmacological investigations on neuroprotective efficacy of melatonin-related indoles.
Journal of Pineal Research 05/2006; 40(3):259-69. · 5.79 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A series of 3,3-dimethyl-1-(isoxazol-3-yl)triazenes, potential anticancer agents, were studied by electron impact (EI) ionization and fast atom bombardment mass spectrometry. Their behaviour was compared with that of dacarbazine, 5-(3,3-dimethyl-1-triazenyl)-(1H)-imidazole-4-carboxamide, which is employed in the treatment of several neoplastic conditions. An interesting EI-generated decomposition pathway was observed, consisting in the primary formation of [NH2CH3]+ cations, involved in the metabolic pathway of triazenes, as the alkylating agent responsible for the anticancer properties of the drug. A higher thermodynamic stability of the examined compounds than decarbazine was observed, which reasonably reflects the higher chemical stability.
Biological Mass Spectrometry 04/2005; 30(11):1567 - 1573. · 3.41 Impact Factor
-
Valeria Lucini,
Marilou Pannacci,
Francesco Scaglione,
Franco Fraschini,
Sivia Rivara,
Marco Mor,
Fabrizio Bordi,
Pier Vincenzo Plazzi,
Gilberto Spadoni,
Annalida Bedini,
Giovanni Piersanti, Giuseppe Diamantini,
Giorgio Tarzia
[show abstract]
[hide abstract]
ABSTRACT: This work reports the design and synthesis of novel alkylamides, characterized by a dibenzo[a,d]cycloheptene nucleus, as melatonin (MLT) receptor ligands. The tricyclic scaffold was chosen on the basis of previous quantitative structure-activity studies on MT1 and MT2 antagonists, relating selective MT2 antagonism to the presence of an aromatic substituent out of the plane of the MLT indole ring. Some dibenzo seven-membered structures were thus selected because of the noncoplanar arrangement of their benzene rings, and an alkylamide chain was introduced to fit the requirements for MLT receptor binding, namely, dibenzocycloheptenes with an acylaminoalkyl side chain at position 10 and dibenzoazepines with this side chain originating from the nitrogen atom bridging the two phenyl rings. Binding affinity at human cloned MT1 and MT2 receptors was measured by 2-[125I]iodomelatonin displacement assay and intrinsic activity by the GTPgammaS test. The majority of the compounds were characterized by higher affinity at the MT2 than at the MT1 receptor and by very low intrinsic activity values, thus confirming the importance of the noncoplanar arrangement of the two aromatic rings for selective MT2 antagonism. Dibenzocycloheptenes generally displayed higher MT1 and MT 2affinity than dibenzoazepines. N-(8-Methoxy-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-10-ylmethyl)propionamide (4c) and -butyramide (4d) were the most selective MT2 receptor antagonists of the series, with MT2 receptor affinity comparable to that of melatonin and as such among the highest reported in the literature for MLT receptor antagonists. The acetamide derivative 4b produced a noticeable reduction of GTPgammaS binding at MT2 receptor, thus being among the few inverse agonists described.
Journal of Medicinal Chemistry 09/2004; 47(17):4202-12. · 5.25 Impact Factor
-
Marco Mor,
Claudia Silva,
Federica Vacondio,
Pier Vincenzo Plazzi,
Simona Bertoni,
Gilberto Spadoni, Giuseppe Diamantini,
Annalida Bedini,
Giorgio Tarzia,
Morena Zusso,
Davide Franceschini,
Pietro Giusti
[show abstract]
[hide abstract]
ABSTRACT: The known neuroprotective actions of melatonin could be due to its antioxidant or radical scavenging activity, or they could be due to specific interactions of the indole with its receptors. A study of structure-activity relationships may provide useful information when a validated macromolecular target has not been (or is not) identified. A set of indole derivatives, with changes in the 5-methoxy and acylamino groups, the side chain position and the lipophilic/hydrophilic balance, were selected and tested for their in vitro antioxidant potency in the ABTS (2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid disodium salt) and thiobarbituric acid reactive substances (TBARS) assays and for their cytoprotective activity against kainate excitotoxicity on cerebellar cell cultures. No quantitative model was able to relate the potencies obtained in the two antioxidant assays, probably because they are related to different physico-chemical properties. However, the lipophilicity of the compounds and the antioxidant potency in the TBARS assay were linearly correlated. This may be due to improved access to the lipidic substrate, where the antioxidant action occurs. In the cytoprotection assay, most compounds showed potencies comparable with or lower than melatonin. An exception was N-[2-(5-methoxy-1H-indol-2-yl)ethyl]acetamide (12), yielding, at 50 microM, percentages of cell vitality higher than 75%, while melatonin EC50 was 333 microM. No correlation was observed between cytoprotective and antioxidant potencies, nor with MT1 or MT(2) receptor affinity. Compound 12 is a low-affinity antagonist at melatonin membrane receptors, and one of the most potent compounds in the antioxidant assays; its cytoprotective potency and the absence of agonist activity at melatonin membrane receptors make it a valid candidate for further investigations.
Journal of Pineal Research 04/2004; 36(2):95-102. · 5.79 Impact Factor
-
Marco Mor,
Gilberto Spadoni, Giuseppe Diamantini,
Annalida Bedini,
Giorgio Tarzia,
Claudia Silva,
Federica Vacondio,
Mirko Rivara,
Pier Vincenzo Plazzi,
Davide Franceschini,
Morena Zusso,
Pietro Giusti
[show abstract]
[hide abstract]
ABSTRACT: Melatonin (MLT) is known for its radical scavenger activity, which had been related to its ability to protect neuronal cells from different kinds of oxidative stress. In particular, MLT protects rat cerebellum granular cells from kainate-induced necrosis at concentrations higher than 100 microM, and is able to reduce lipoperoxidation induced by radical stress in rat brain homogenate at similar concentrations. On the other hand, MLT has nanomolar affinity for its membrane receptors (MT1 and MT2), and these are completely saturated at the high concentrations employed when the cytoprotective effect is observed. Other indole derivatives are also known to possess antioxidant and cytoprotective activity. In order to dissociate the cytoprotective effect of MLT from its receptor affinity, and to investigate the structure-activity relationships (SAR) between this effect and some potentially relevant chemical properties, we prepared a series of indole derivatives, where the structure of MLT was gradually modulated, varying the 5-methoxy group nature and position, the acylaminoethyl chain position, and by the introduction of lipophilic groups. These modifications resulted in a set of compounds having different receptor affinity and intrinsic activity, different lipophilicity, and different substitution at the indole nucleus. The compounds were tested for their antioxidant potency by the ABTS test and by inhibition of rat brain homogenate lipoperoxidation; their cytoprotective effect was also estimated from the inhibition of kainate-induced cellular death on rat cerebellum granular cells, and the results were evaluated by SAR comparison and QSAR analysis. An isomer of MLT resulted more potent and effective than MLT itself in the cytoprotection test, although it showed similar potency in the peroxidation test, and it was devoid of the ability to stimulate MT1 and MT2 receptors. This compound was selected as the lead compound for a further SAR study, devoted to the optimization of the cytoprotective effect and to the investigation on its mechanism.
Advances in experimental medicine and biology 02/2003; 527:567-75. · 1.09 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The protective effects of selected members from a series of caffeic acid esters and flavonoids were tested in various toxicity paradigms using U937 cells, previously shown to be sensitive to either iron chelators or bona fide radical scavengers or to both classes of compounds. It was found that all the protective polyphenols were active at very low concentrations and that their effects were observed only under those conditions in which iron chelators also afforded protection. Consistently, active polyphenolic compounds, unlike the inactive ones, effectively chelated iron in an in vitro system. It follows that, at least under the experimental conditions utilized in the present study, the most prominent activity of these polyphenolic compounds resides in their ability to chelate iron. Further studies revealed that the protective effects afforded by the caffeic acid esters and flavonoids were largely mediated by the catechol moiety and that the relative biological potency of these compounds was a direct function of their lipophilicity.
Biochemical Journal 06/2002; 364(Pt 1):121-8. · 4.90 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: We review our work towards the design and synthesis of high-affinity melatonin (N-acetyl-5-methoxytryptamine) agonist and antagonist compounds. High affinity melatonergic agonists were obtained by shifting the melatonin side chain from C3 to N1 of the indole ring system. Conversely, by moving the side chain from C3 to C2 it was possible to obtain melatonin antagonist compounds, albeit of moderate affinity.
Il Farmaco 04/2000; 55(3):184-187.
